BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

PharmAbcine's Novel Antibody Approved for Clinical Trial in nAMD

The Phase I clinical trial is an open-label, multi-center, single and multiple ascending-dose study to assess safety, tolerability, MTD (maximum tolerated ...

May 24, 2023 | News

FDA Clears New Insulin Pump and Algorithm-Based Software for Enhanced Insulin Delivery

U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with t...

May 22, 2023 | News

Australia Diabetes Market Projected to Reach $5.96 Billion by 2028, Reports Research and Markets

Research and Markets, a leading market research company, has released a report on the Australia Diabetes Market projecting it to reach ...

April 02, 2023 | News

Astellas and Roche Diabetes Care Japan Partner to Develop Integrated Diabetes Self-Management Solution

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it has entered into an agreement ("the Agr...

March 29, 2023 | News

Journey Biosciences Selected as First Company for StartUp Health's Type 1 Diabetes Moonshot

Journey Biosciences, a pioneer of predictive screenings for diabetes-related complications, today announced that it has become the first company to receive...

March 24, 2023 | News

Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month

Lilly is reducing the list price of insulins by: Cutting the list price of its non-branded insulin, Insulin Lispro Injection 100 units/mL, to $25&n...

March 03, 2023 | News

"Anura™ contactless health monitoring tech to integrate with mobile devices

Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera NuraLogix, a global pioneer of ...

February 27, 2023 | News

GlycoMark® test predicts diabetes risk in prediabetic individuals

A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard diabetes tests, ...

February 22, 2023 | News

No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes

Partnership agreed to miniaturize a non-invasive glucose sensor for your wrist Minilaser-based technology to make life easier for diabetes patients Mor...

January 09, 2023 | News

New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances

The groundbreaking consensus statement, endorsed by numerous leading US and international diabetes organizations, including the American Association of Cli...

December 07, 2022 | News

Life After Stroke

According to the American Stroke Association, a division of the American Heart Association, each year, approximately 800,000 people in the United...

November 22, 2022 | News

LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

Early customers include GP offices and other community-based healthcare settings Latest figures, released as part of World Diabetes Day, reveal that 1 i...

November 15, 2022 | News

ITRI Introduces Point-of-Care AI-DR Software for Rapid Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema

The Industrial Technology Research Institute (ITRI), Taiwan's largest and one of the world's leading high-tech applied research institutions...

November 11, 2022 | News

1 in 2 diabetics suffer from Peripheral Neuropathy[1] during their lifetime : P&G

P&G Health, makers of Neurobion, embark on an effort to help people 'Put Life Back in Their Hands' for an improved quality of life. Launched...

November 08, 2022 | News

Stay Connected